Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?Does lipitor's use influence blood pressure medication type?When is the expected fda decision date for apotex's ruxolitinib resubmission?Drug patent watch trametinib?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Terazosin
Terazosin Chemical Structure Terazosin, a non-selective α1-adrenergic receptor antagonist used in the treatment of hypertension and benign prostatic hyperplasia, has a chemical structure consisting of a phenothiazine ring system. Phenothiazine Ring System [1] The phenothiazine ring system in terazosin is a planar, six-membered ring featuring a sulfur atom (S) and two nitrogen atoms (N). This ring system is responsible for the compound's α1-adrenergic blocking activity. R-Group Substituents [1] The terazosin molecule has a number of R-group substituents attached to the phenothiazine ring system, including a piperazine ring, a methyl (CH3) group, and an ethyl (C2H5) group. Simplified Chemical Structure Here is a simplified representation of the terazosin chemical structure: C20H25N3O4S References [1] https://www.drugpatentwatch.com/lookup?term=terazosin (Source: DrugPatentWatch.com) Sources 1. https://www.drugpatentwatch.com/lookup?term=terazosin
Other Questions About Terazosin :